Journal of cardiothoracic and vascular anesthesia (J Cardiothorac Vasc Anesth)

Publications in this journal

• Article: Intrathecal Morphine: The Forgotten Child.

  Edmond Cohen
  Journal of cardiothoracic and vascular anesthesia 06/2013; 27(3):413-416.
• Article: Epidural Versus ON-Q Local Anesthetic-Infiltrating Catheter for Post-Thoracotomy Pain Control.

  Rodolfo Gebhardt, Reza John Mehran, Jose Soliz, Juan P Cata, Ashley K Smallwood, Thomas W Feeley
  [show abstract] [hide abstract]
  ABSTRACT: OBJECTIVE: The authors compared thoracic epidural with ON-Q infiltrating catheters in patients having open thoracotomy to determine whether one method better relieves postoperative pain and would allow earlier discharge from the hospital and, hence, cost savings. DESIGN: Retrospective chart review. SETTING: University hospital. PARTICIPANTS: Fifty adult patients (24 to 81 years old) undergoing open thoracotomy by one surgeon. INTERVENTIONS: One group had thoracic epidural catheters placed by an anesthesiologist and then managed by the acute pain service. The other group had intraoperative ON-Q (ON-Q; I-Flow; Lake Forest, California) infiltrating catheters placed by the surgeon, wound infiltration with a local anesthetic, plus patient-controlled analgesia with an intravenous opioid. MEASUREMENTS AND MAIN RESULTS: The authors measured and compared average daily pain rating, maximum pain rating, time to discharge from the hospital, and total bill for hospital stay. Patients who received epidural analgesia had lower average pain scores on day 2 than did patients in the ON-Q group. Patients in the ON-Q group reported higher maximum pain scores on days 1 and 2 and at the time of discharge. Patients in the ON-Q group were discharged an average of 1 day earlier; hence, their average total bill was lower. CONCLUSIONS: Even though the maximum pain score was higher in the ON-Q group, patients were comfortable enough to be discharged earlier, resulting in cost savings. ON-Q infiltrating catheters present a good option for providing postoperative analgesia to patients having an open thoracotomy.
  Journal of cardiothoracic and vascular anesthesia 06/2013; 27(3):423-426.
• Article: Reply: Summarizing Randomized Evidence With Clinically Relevant Outcomes Performed in the Perioperative Period.

  Giovanni Landoni, Massimiliano Conte, Andrea Székely, Marco Comis, Daniela Pasero, Laura Pasin, Marta Mucchetti, Gianluca Paternoster, Paolo A Del Sarto, Reitze N Rodseth
  Journal of cardiothoracic and vascular anesthesia 06/2013; 27(3):e29-e30.
• Article: Reply: Further Studies Ought to Evaluate the Cardiac Output Measurement by Nexfin Device.

  F Trinkmann, J Saur
  Journal of cardiothoracic and vascular anesthesia 06/2013; 27(3):e36-e37.
• Article: Difficulty in the Diagnosis of a Retained Guidewire Within the Central Venous Catheter.

  Goneppanavar Umesh, Thomas Joseph Tim, Anu Paul, Abdul Samad Amjad
  Journal of cardiothoracic and vascular anesthesia 06/2013; 27(3):e25-e26.
• Article: Progress in Platelet Blockers: The Target is the P2Y12 Receptor.

  Prakash A Patel, Bernard Lane, John G T Augoustides
  [show abstract] [hide abstract]
  ABSTRACT: The considerable progress in P2Y12-platelet blockers has important perioperative implications due to a family of novel agents beyond clopidogrel. Although prasugrel is more potent than clopidogrel due to more efficient hepatic metabolism, it is limited clinically by its irreversibility and bleeding risks. Ticagrelor, as the first approved direct and reversible oral P2Y12 blocker, still is limited clinically by its novel side-effect profile. Intravenous reversible P2Y12 blockade is possible now with both cangrelor and elinogrel, although both agents are still in clinical development. Furthermore, elinogrel offers the possibility of both oral and parenteral P2Y12 blockade with a single agent. Future trials likely will continue to evaluate and compare the safety and efficacy of these agents in multiple clinical settings, including the perioperative period.
  Journal of cardiothoracic and vascular anesthesia 06/2013; 27(3):620-624.
• Article: Bronchial Blocker Versus Double-Lumen Tube for Lung Isolation With Massive Hemoptysis During Cardiac Surgery.

  Hamdy Awad, Obaid Malik, Kevin Hollis, Michelle Santiago, Shaheen Islam, Juan A Crestanello
  Journal of cardiothoracic and vascular anesthesia 06/2013; 27(3):e26-e28.
• Article: Should High Thoracic Epidural Analgesia Be Dismissed in Cardiac Surgery?

  Yong X Liang, He Dong, Jian F Song
  Journal of cardiothoracic and vascular anesthesia 06/2013; 27(3):e32.
• Article: Thoracic Epidural Anesthesia Improves Early Outcome in Patients Undergoing Cardiac Surgery for Mitral Regurgitation: A Propensity-Matched Study.

  Fabrizio Monaco, Camilla Biselli, Giovanni Landoni, Monica De Luca, Rosalba Lembo, Remo Daniel Covello, Alberto Zangrillo
  [show abstract] [hide abstract]
  ABSTRACT: OBJECTIVE: There are no large studies that investigate the effect of thoracic epidural anesthesia (TEA) combined with general anesthesia (GA) in patients undergoing valvular surgery. The authors hypothesized that TEA might improve clinically relevant endpoints in patients with primary mitral regurgitation. DESIGN: Propensity-matched study. SETTING: Cardiac surgery. PARTICIPANTS: Patients scheduled for mitral valve repair or replacement were studied. INTERVENTIONS: A propensity model was constructed to match 33 patients receiving TEA combined with GA with 33 patients receiving standard GA alone. MEASUREMENTS AND MAIN RESULTS: Overall, the TEA group suffered fewer adverse events than the GA group: 10 (30%) v 23 (10%) with p = 0.002. In particular, the TEA group had a lower incidence of pulmonary events, 6 (18%) v 15 (45%) with p = 0.02, and of cardiac events, 8 (24%) v 16 (49%) with p = 0.04. Median (interquartile) time on mechanical ventilation was reduced in the TEA group, 11 (9-15) v 17 (12-36) with p = 0.007. CONCLUSIONS: This propensity-matched study suggested that TEA might be advantageous in patients undergoing surgery for mitral regurgitation.
  Journal of cardiothoracic and vascular anesthesia 06/2013; 27(3):445-450.
• Article: Anesthetic Management of Robotically Assisted Totally Endoscopic Coronary Artery Bypass Surgery (TECAB).

  Seema P Deshpande, Eric Lehr, Patrick Odonkor, Johannes O Bonatti, Maudy Kalangie, David A Zimrin, Alina M Grigore
  Journal of cardiothoracic and vascular anesthesia 06/2013; 27(3):586-599.
• Article: The Problems of Using Unreliable Evidence in Consensus Group Decision-Making.

  R Peter Alston, Victoria McMullan
  Journal of Cardiothoracic and Vascular Anesthesia 06/2013; 27(3):e28-e29.
• Article: Major Pulmonary Embolism and Patent Foramen Ovale.

  Julie Alingrin, Aude Carillion, Angeline Martin, Yves Saade, Jean-Marc Malinovsky
  Journal of cardiothoracic and vascular anesthesia 06/2013; 27(3):e30-e31.
• Article: Imperfect 'Swan'

  Madan Mohan Maddali, Mona Dsouza, Salim Nasser Al-Maskari
  Journal of cardiothoracic and vascular anesthesia 06/2013; 27(3):e32-e34.
• Article: High Thoracic Epidural Analgesia and Cardiac Performance.

  Yong Xin Liang, He Dong, Yun Bo Sun
  Journal of cardiothoracic and vascular anesthesia 06/2013; 27(3):e34-e35.
• Article: Further Studies Should Evaluate Cardiac Output Measurement by the Nexfin Device.

  Sevket Balta, Mehmet Aydogan, Ugur Kucuk, Sait Demırkol, Murat Unlu, Zekeriya Arslan
  Journal of cardiothoracic and vascular anesthesia 06/2013; 27(3):e35-e36.
• Article: Reply: High Thoracic Epidural Analgesia and Cardiac Performance.

  Carl-Johan Jakobsen, Dorthe Viemose Nielsen, Pia Katarina Ryhammer, Rajesh Bhavsar, Erik Sloth, Jacob Greisen
  Journal of cardiothoracic and vascular anesthesia 06/2013; 27(3):e35.
• Article: Neurocognitive Outcomes of Cardiac Surgery: A Review.

  Suzan Uysal, David L Reich
  Journal of cardiothoracic and vascular anesthesia 05/2013;
• Article: Intravenous Flurbiprofen Axetil Can Stabilize the Hemodynamic Instability Due to Mesenteric Traction Syndrome-Evaluation with Continuous Measurement of the Systemic Vascular Resistance Index using a FloTrac(®) Sensor.

  Motoshi Takada, Chieko Taruishi, Tomoko Sudani, Akira Suzuki, Hiroki Iida
  [show abstract] [hide abstract]
  ABSTRACT: OBJECTIVE: Evaluation of the stabilizing effect of intravenous flurbiprofen axetil against hemodynamic instability due to mesenteric traction syndrome (MTS) by continuous measurement of systemic vascular resistance index (SVRI) using a FloTrac(®) sensor was evaluated. DESIGN: Prospective randomized trial. SETTING: A single-center study performed in an educational hospital. PARTICIPANTS: Two prospective studies were carried out, each with 40 patients scheduled for elective open abdominal surgery. INTERVENTION: Twenty patients received 50mg of flurbiprofen axetil after the recognition of MTS by the anesthesiologist (group FT). The remaining patients served as controls (groups CP and CT). MEASUREMENTS AND MAIN RESULTS: SVRI data was collected every 20 seconds for 1 hour after starting the laparotomy. The average SVRI prior to skin incision was taken as the baseline. Following 3 values were devised to evaluate MTS: the S-value (sum total of changes in SVRI from baseline), the T-value (period during which SVRI remained 20% or more below baseline), and the M-value (maximum change in SVRI from baseline). In group FP, decrease in SVRI was smaller than in group CP, and statistical differences in the 3 values were found. In group FT, SVRI recovered earlier than in group CT, and statistical differences were found in S-value and T-value. However, the M-value had no statistical differences. CONCLUSIONS: Intravenous flurbiprofen axetil can stabilize the hemodynamic instability due to MTS.
  Journal of cardiothoracic and vascular anesthesia 05/2013;
• Article: ADP-Receptor Inhibitors in the Perioperative Period: The Good, the Bad, and the Ugly.

  Adriana Dana Oprea, Wanda M Popescu
  Journal of cardiothoracic and vascular anesthesia 05/2013;
• Article: Transesophageal Echocardiography During Orthotopic Liver Transplantation: Maximizing Information Without the Distraction.

  Amy C Robertson, Susan S Eagle
  Journal of cardiothoracic and vascular anesthesia 04/2013;